Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |